Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Tajikistan: Access to anti-retroviral drugs, female
Access to anti-retroviral drugs, female over time
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
- Tajikistan
How they compare
Tajikistan currently reports 95.0% against 38.4% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 56.6%.
That makes Tajikistan's figure about 2.5 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ahead.
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th and Tajikistan ranks 19th of 19 groups.
Across the 3 decades both report, Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) averaged higher in 1 and Tajikistan in 2.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.8% | 0.7% | 3.1% | Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) |
| 2010s | 20.3% | 29.8% | 9.5% | Tajikistan |
| 2020s | 34.3% | 83.4% | 49.1% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) or Tajikistan?
- Tajikistan, at 95.0% against 38.4% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Tajikistan?
- 56.6%, with Tajikistan ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Tajikistan?
- 25 years are reported by both, from 2000 to 2024.
- How do Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Tajikistan rank globally for access to anti-retroviral drugs, female?
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th and Tajikistan ranks 19th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.